Contact | Alessandro Doria | Harvard T.H. Chan School of ...
www.hsph.harvard.edu/alessa...
Harvard T.H. Chan School of Public Health
Michael Mauer, MD - Department of Pediatrics - University of ...
www.peds.umn.edu/nephrology/.../michael-mau...
University of Minnesota
The below research should compare BCG with allopurinol and not Allopurinol with a placebo
Research such as the below does not address the immune system and/or take a wholistic view of the disease process. There is much bad science and/art as there are auto mechanics who swap parts without a procedural approach.
Write to the below authors and help educate them and test the openness and flexibility of their minds.
Results: 2
1.
Maahs DM, Caramori L, Cherney DZ, Galecki AT, Gao C, Jalal D, Perkins BA, Pop-Busui R, Rossing P, Mauer M, Doria A; PERL Consortium.
Curr Diab Rep. 2013 Aug;13(4):550-9. doi: 10.1007/s11892-013-0381-0. Review.
- PMID:
- 23649945
2.
Doria A, Niewczas MA, Fiorina P.
Semin Nephrol. 2012 Sep;32(5):437-44. doi: 10.1016/j.semnephrol.2012.07.006.
- PMID:
- 23062984
Related citations
GOOD SCIENCE AND ART IS THE WORK OF DR DENISE L FAUSTMAN AND THE TNF-ALPHA WORKING GROUP.
SUPPORT DR DENISE L FAUSTMAN
SHOOT BCG
SHOOT ME WITH BCG AND PUT ME ON YOU TUBE.
BCG, SAFE, CHEAP AND EFFECTIVE
Dr. Faustman's type 1 diabetes research has earned her notable awards such as the Oprah Achievement Award for “Top Health Breakthrough by a Female Scientist” (2005), the "Women in Science Award" from the American Medical Women’s Association and Wyeth Pharmaceutical Company for her contributions to autoimmune disease research (2006), and the Goldman Philanthropic Partnerships/Partnership for Cures “George and Judith Goldman Angel Award” for research to find an effective treatment for type 1 diabetes (2011). Her previous research accomplishments include the first scientific description of modifying donor tissue antigens to change their foreignness. This achievement earned her the prestigious National Institutes of Health and National Library of Medicine “Changing the Face of Medicine” Award (2003) as one of 300 American physicians (one of 35 in research) honored for seminal scientific achievements in the United States.
Dr. Faustman earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in Internal Medicine and Endocrinology at the Massachusetts General Hospital in Boston, Massachusetts.
GOOD SCIENCE AND ART IS THE WORK OF DR DENISE L FAUSTMAN AND THE TNF-ALPHA WORKING GROUP.
SUPPORT DR DENISE L FAUSTMAN
SHOOT BCG
SHOOT ME WITH BCG AND PUT ME ON YOU TUBE.
BCG, SAFE, CHEAP AND EFFECTIVE
Quick Links
> Clinical Trials Info
>Sign up for e-mail updates
>Support the Faustman Lab
>Host an event or fundraiser
>Patient information forms
> Clinical Trials Info
>Sign up for e-mail updates
>Support the Faustman Lab
>Host an event or fundraiser
>Patient information forms
Your donation will directly support our Phase II research.
Raised to date: $18.4 million
Our total need: $25.2 million.
Raised to date: $18.4 million
Our total need: $25.2 million.
------------
Interested in the Phase II Trial?
The Faustman Lab at Massachusetts General Hospital
Denise Faustman, MD, PhD, is Director of the Immunobiology
Laboratory at the Massachusetts General Hospital (MGH) and an Associate
Professor of Medicine at Harvard Medical School. Her current research
focuses on discovering and developing new treatments for type 1 diabetes
and other autoimmune diseases, including Crohn's disease, lupus,
scleroderma, rheumatoid arthritis, Sjögren's syndrome, and multiple
sclerosis. She is currently leading a human clinical trial program
testing the efficacy of the BCG vaccine for reversal of long-term type 1
diabetes. Positive results from the Phase I study were reported in 2012.Dr. Faustman's type 1 diabetes research has earned her notable awards such as the Oprah Achievement Award for “Top Health Breakthrough by a Female Scientist” (2005), the "Women in Science Award" from the American Medical Women’s Association and Wyeth Pharmaceutical Company for her contributions to autoimmune disease research (2006), and the Goldman Philanthropic Partnerships/Partnership for Cures “George and Judith Goldman Angel Award” for research to find an effective treatment for type 1 diabetes (2011). Her previous research accomplishments include the first scientific description of modifying donor tissue antigens to change their foreignness. This achievement earned her the prestigious National Institutes of Health and National Library of Medicine “Changing the Face of Medicine” Award (2003) as one of 300 American physicians (one of 35 in research) honored for seminal scientific achievements in the United States.
Dr. Faustman earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in Internal Medicine and Endocrinology at the Massachusetts General Hospital in Boston, Massachusetts.
No comments:
Post a Comment